The Telegraph: Warning over global failure to act on deaths from drug-resistant TB
“The spiraling number of deaths from drug-resistant tuberculosis (DR-TB) is set to cost the world economy nearly $20 billion annually. A report from the Economist Intelligence Unit warned that despite the fact that DR-TB is a huge global health threat, the fight against the disease lags behind others in terms of both money and attention. In low- and middle-income countries, where 97 percent of the TB cases took place in 2018, there was an estimated $3.5 billion shortfall in the total $10 billion budget required to address the disease. … The EIU and Johnson & Johnson report called for the disease to be treated as a public health emergency and said $9 billion was needed to develop new drugs, diagnostics, and vaccines…” (Wallen, 5/9).